Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein

Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?

(2016) Irina Isakova-Sivak et al.   Expert Review of Vaccines

Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

(2016) Shin-ichi Tamura et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial

(2016) Larisa Rudenko et al.   LANCET INFECTIOUS DISEASES

H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets

(2016) Jørgen de Jonge et al.   MOLECULAR THERAPY

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins

(2016) Hillary A. Vanderven et al.   EBioMedicine

Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice

(2015) Wenling Wang et al.   Clinical and Vaccine Immunology

Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus

(2015) Larisa Rudenko et al.   Expert Review of Vaccines

Strategies towards universal pandemic influenza vaccines

(2015) Fang He et al.   Expert Review of Vaccines

Positive Selection in CD8+T-Cell Epitopes of Influenza Virus Nucleoprotein Revealed by a Comparative Analysis of Human and Swine Viral Lineages

(2015) Heather M. Machkovech et al.   JOURNAL OF VIROLOGY

Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: Results from a placebo-controlled, randomized double-blind phase I study

(2015) Larisa Rudenko et al.   VACCINE

H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers

(2015) Irina Isakova-Sivak et al.   Human Vaccines & Immunotherapeutics

Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses

(2015) Peter Christiaan Soema et al.   Frontiers in Immunology

Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model

(2014) Irina Isakova-Sivak et al.   Clinical and Vaccine Immunology

Development of live attenuated influenza vaccines against pandemic influenza strains

(2014) Kathleen L Coelingh et al.   Expert Review of Vaccines

Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine

(2014) Larisa Rudenko et al.   PLoS One

Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus

(2014) Irina Isakova-Sivak et al.   PLoS One

Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge

(2013) Xiao Gao et al.   ANTIVIRAL RESEARCH

Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance

(2011) M. W. LaMere et al.   JOURNAL OF VIROLOGY

Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine

(2011) G. L. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries

(2011) Larisa Rudenko et al.   VACCINE

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2)

(2011) Irina Isakova-Sivak et al.   VIROLOGY

Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses

(2010) Graeme E. Price et al.   PLoS One

Antigen Specific In Vivo Killing Assay using CFSE Labeled Target Cells

(2010) Marina Durward et al.   Jove-Journal of Visualized Experiments